The issue of how predict survival of patients affected by locally advanced pancreatic cancer.
作者信息
Ielpo Benedetto
机构信息
HPB Unit, General Surgery, University Hospital of Leon, Calle Altos de Nava s/n León, Spain.
出版信息
Ann Transl Med. 2018 Dec;6(Suppl 2):S128. doi: 10.21037/atm.2018.12.41.
Abstract
摘要
相似文献
1
The issue of how predict survival of patients affected by locally advanced pancreatic cancer.如何预测局部晚期胰腺癌患者的生存率这一问题。
Ann Transl Med. 2018 Dec;6(Suppl 2):S128. doi: 10.21037/atm.2018.12.41.
2
Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.经皮不可逆电穿孔治疗局部晚期和复发性胰腺癌（PANFIRE-2）：一项多中心、前瞻性、单臂、二期研究。
Radiology. 2020 Jan;294(1):212-220. doi: 10.1148/radiol.2019191109. Epub 2019 Nov 5.
3
Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer.放化疗对局部晚期不可切除胰腺癌进行优化治疗的临床效果
Br J Radiol. 2017 Jul;90(1075):20170165. doi: 10.1259/bjr.20170165. Epub 2017 Jun 7.
4
FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan.FOLFIRINOX 方案治疗局部进展期胰腺癌：来自日本全国多中心观察性研究的亚组分析结果和预后因素。
Pancreatology. 2019 Mar;19(2):296-301. doi: 10.1016/j.pan.2019.01.001. Epub 2019 Jan 4.
5
Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.局部晚期胰腺癌的术前化疗、放疗及手术切除
Arch Surg. 2000 Jan;135(1):81-7; discussion 88. doi: 10.1001/archsurg.135.1.81.
6
Locally advanced pancreas cancer: Staging and goals of therapy.局部进展期胰腺癌：分期和治疗目标。
Surgery. 2018 May;163(5):1053-1062. doi: 10.1016/j.surg.2017.09.012. Epub 2018 Jan 10.
7
A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study.一种用于预测接受胰体尾癌根治性切除联合腹腔干整块切除的局部晚期胰体癌患者预后的新术前预后评分系统：一项回顾性队列研究。
Surgery. 2014 Mar;155(3):457-67. doi: 10.1016/j.surg.2013.10.024. Epub 2013 Nov 2.
8
Microwave ablation in locally advanced pancreatic carcinoma--a new look.局部晚期胰腺癌的微波消融——新视角
Hepatogastroenterology. 2007 Jul-Aug;54(77):1305-10.
9
Implantation of radioactive (125)I seeds improves the prognosis of locally advanced pancreatic cancer patients: A retrospective study.放射性（125）I 粒子植入改善局部晚期胰腺癌患者预后：一项回顾性研究。
J Huazhong Univ Sci Technolog Med Sci. 2016 Apr;36(2):205-210. doi: 10.1007/s11596-016-1567-x. Epub 2016 Apr 13.
10
Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer.新辅助治疗后局部进展期“不可切除”胰腺癌的切除术。
Surgery. 2012 Sep;152(3 Suppl 1):S33-42. doi: 10.1016/j.surg.2012.05.029. Epub 2012 Jul 6.
引用本文的文献
1
Central vascular ligation and mesentery based abdominal surgery.中心血管结扎术及基于肠系膜的腹部手术。
Discov Oncol. 2021 Aug 6;12(1):24. doi: 10.1007/s12672-021-00419-4.
本文引用的文献
1
Neoadjuvant therapy: theoretical, biological and medical consideration.新辅助治疗：理论、生物学及医学考量
Chin Clin Oncol. 2018 Dec;7(6):55. doi: 10.21037/cco.2018.09.05.
2
How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort.诱导化疗后 FOLFIRINOX 方案联合放化疗对可切除交界性或局部进展期胰腺导管腺癌患者的疗效改善作用：AGEO-FRENCH 多中心队列研究。
Ann Surg Oncol. 2019 Jan;26(1):109-117. doi: 10.1245/s10434-018-6931-6. Epub 2018 Oct 25.
3
A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy.局部进展期胰腺癌患者接受放化疗后生存预测的列线图。
Radiother Oncol. 2018 Nov;129(2):340-346. doi: 10.1016/j.radonc.2018.08.006. Epub 2018 Aug 31.
4
A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma.吉西他滨联合纳米白蛋白紫杉醇新辅助治疗与先行手术治疗胰腺腺癌的对比研究
Surg Oncol. 2017 Dec;26(4):402-410. doi: 10.1016/j.suronc.2017.08.003. Epub 2017 Aug 24.
5
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.《胰腺导管腺癌临床实践指南（2017 年第 2 版）》，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.
6
Pancreatic cancer.胰腺癌。
Nat Rev Dis Primers. 2016 Apr 21;2:16022. doi: 10.1038/nrdp.2016.22.
7
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.吉西他滨联合或不联合厄洛替尼治疗 4 个月后局部进展期胰腺癌患者生存的影响：LAP07 随机临床试验。
JAMA. 2016 May 3;315(17):1844-53. doi: 10.1001/jama.2016.4324.
8
Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma.吉西他滨联合纳米白蛋白紫杉醇术前治疗是一种安全有效的胰腺腺癌化疗方法。
Eur J Surg Oncol. 2016 Sep;42(9):1394-400. doi: 10.1016/j.ejso.2016.01.006. Epub 2016 Jan 29.
9
Prognostic significance of volume-based FDG PET/CT parameters in patients with locally advanced pancreatic cancer treated with chemoradiation therapy.基于体积的FDG PET/CT参数在接受放化疗的局部晚期胰腺癌患者中的预后意义。
Yonsei Med J. 2014 Nov;55(6):1498-506. doi: 10.3349/ymj.2014.55.6.1498.
10
Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates?新辅助治疗用于胰腺腺癌会增加术后发病率和死亡率吗？
J Gastrointest Surg. 2015 Jan;19(1):80-6; discussion 86-7. doi: 10.1007/s11605-014-2620-3. Epub 2014 Aug 5.
Zotero 插件